• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, December 9, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Optometry Australia: Wake up, Canberra – country ‘sleepwalking’ into eyecare crisis

by Staff Writer
March 21, 2025
in Associations, Eye disease, Federal Government, Local, Medicare, News, Ophthalmic insights, Ophthalmic organisations, Optometry networks, Policy & regulation
Reading Time: 3 mins read
A A
eye injection incentive

According to Medicare data for 2023, 67% of people having eye injections were not bulk billed. Image: Robyn Mackenzie/Shutterstock.com.

Share on FacebookShare on Twitter

Optometry Australia (OA) is intensifying its election campaign following what it calls “underwhelming responses” from key political parties, warning that Australia is “sleepwalking into an eye health crisis”.

A media release said it was a call to action to coincide with World Optometry Week (17-23 March 2025), which this year carries the theme ‘Eyes to the Future: Optometry Improving Global Wellness’.

“As the world highlights the critical role of optometry in shaping healthier communities, Australia must rise to the occasion or risk falling behind – especially as eye health continues to be deprioritised in national policy discussions,” OA said.

Over 400 optometrists across the country have sent more than 5,500 emails to federal representatives, urging them to reverse the 2014 Budget decision that reduced Medicare-subsidised initial comprehensive eye examinations for under 65s from once every two years to once every three years.

OA said that despite this strong advocacy, political leaders had failed to take action:

  • The Australian Labor Party (ALP) has referred optometrists to the Medicare Services Advisory Committee (MSAC) rather than committing to fixing the issue, leaving change languishing in bureaucracy. [Read Minister Butler’s response here].
  • The Australian Greens have offered only a general commitment to Medicare, but with a focus on dental rather than eyecare.
  • The Coalition has yet to respond at all.
Optometry Australia chief executive Skye Cappuccio. Image: Optometry Australia.

“This lack of action is unacceptable,” said OA chief executive Ms Skye Cappuccio. “If we saw a similar decline in preventative health measures like cancer screenings, the government would act immediately. Instead, eye health is being ignored—and Australians are paying the price.”

OA’s analysis of official Medicare figures found that per capita rates of initial comprehensive eye examinations by people aged under 65 fell by nearly 20% between 2017-18 and 2023-24.

“This alarming drop was in all age cohorts from 0-5 years to 55-64 years, and in all jurisdictions. In fact, in one year, between 2022-23 and 2023-24, there was a 6.2% drop, indicating a likely link to cost-of-living pressures, with per capita rates of initial comprehensive eye examinations now lower than in the heights of the COVID pandemic in 2020-21,” OA said.

“At the same time, chronic eye conditions—including childhood myopia, glaucoma, diabetic retinopathy, and macular degeneration—are rising sharply. Many of these conditions can lead to permanent vision loss if not detected early, yet routine eye exams remain out of reach for too many Australians.”

With neither major party taking real action, OA said it was no longer advocating quietly behind the scenes.

“Our members are stepping up, meeting MPs, sharing patient stories, and demanding action,” said Cappuccio. “If optometry is ignored this election, it won’t be because we stayed quiet.

“At the moment, the major parties are on a unity ticket to ignore eyecare. This has to change – Canberra may be happy to ignore eye health, but Australians shouldn’t.”

More reading

Optometry Australia says health insurance rules a ‘minefield’

Private health cover ending for intravitreal injections in hospital setting

Liberal and Labor vow to maintain intravitreal injection MBS rebate

 

Related Posts

Actress and entrepreneur Naomi Watts is promoting eye health as part of healthy ageing. Image: Denis Makarenko/shutterstock.com.

Aussie star Watts, J&J team up to promote eye health

by Staff Writer
December 9, 2025

Johnson & Johnson, a global leader in eye health, has partnered with Australian Academy Award–nominated actress, producer, and entrepreneur Ms...

Mr Mark Nevin began his professional life as an
optometrist in Ireland and the UK. Image: Optometry Australia

Optometry Australia announces new CEO

by Staff Writer
December 9, 2025

Optometry Australia (OA) has appointed Mr Mark Nevin as CEO, following the departure of Ms Skye Cappuccio, who was at...

Holly Cafe worked her way through nearly every role on the retail side during her journey to partnership. Image: Holly Cafe.

Owning the vision – pathways to partnership

by Rhiannon Bowman and Rob Mitchell
December 8, 2025

Three dispensing and retail directors tell Insight how they made their way to investing in an optometry practice – sometimes...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited